Immune checkpoint inhibitor tumor regression may indicate which patients with hepatocellular carcinoma experience improved ...

When I was in my mid-30s over 40 years ago, I was talking to an elementary school principal and former neighbor that I had ...

For unresectable or metastatic liver cancer, the TPST-1120-301 trial of amezalpat combination therapy has received a “Study ...

The advantages and disadvantages of CAR-T cell therapy should be carefully thought about for patients with melanoma.